Table 5.

Diagnostic accuracy of the biomarkers for average and high-risk women

Cases vs healthy controls
Cases vs benign controls
AUCSensitivity at 95% specificitySensitivity at 98% specificityAUCSensitivity at 95% specificitySensitivity at 98% specificity
    AUC differences P*0.980.45
    AUC differences P*0.360.42
    AUC differences P*0.940.69
  • * The AUC differences between the average- and high-risk women were compared for each biomarker using the nonparametric methods developed by DeLong (29).